FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Dimethyl topics
Physiologic
Hydrochloric Acid
Fresnel Zone
Aberration
Ophthalmic
Liquid Crystal
Imaging System
Pharmaceutically Acceptable Salt
Pharmaceutically Acceptable Salts
Chloric Acid
Tartaric Acid
Fumaric Acid
Antagonist
Bradykinin
Enantiomer

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Dimethyl patents



      
           
This page is updated frequently with new Dimethyl-related patent applications. Subscribe to the Dimethyl RSS feed to automatically get the update: related Dimethyl RSS feeds. RSS updates for this page: Dimethyl RSS RSS


Visible light responsive photocatalyst by hydrophilic modification using polymer material and a method for preparing the…

Visible light responsive photocatalyst by hydrophilic modification using polymer material and a method for preparing the…

Date/App# patent app List of recent Dimethyl-related patents
04/23/15
20150112100
 Bio-based terephthalate polyesters patent thumbnailnew patent Bio-based terephthalate polyesters
Bio-based terephthalic acid (bio-tpa), bio-based dimethyl terephthalate (bio-dmt), and bio-based polyesters, which are produced from a biomass containing a terpene or terpenoid, such as limonene are described, as well as the process of making these products. The bio-based polyesters include poly(alkylene terephthalate)s such as bio-based poly(ethylene terephthalate) (bio-pet), bio-based poly(trimethylene terephthalate) (bio-ptt), bio-based poly(butylene terephthalate) (bio-pbt), and bio-based poly(cyclohexylene dimethyl terephthalate) (bio-pct)..
Sabic Innovative Plastics Ip B.v.
04/23/15
20150111964
 Polymorphic salt of a metap-2 inhibitor and methods of making and using same patent thumbnailnew patent Polymorphic salt of a metap-2 inhibitor and methods of making and using same
The disclosure is in part directed to crystalline forms of an oxalate salt of 6-o-(4-dimethylaminoethoxy)cinnamoyl fumagillol.. .
Zafgen, Inc.
04/23/15
20150111939
 Pharmaceutical dosage forms comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine patent thumbnailnew patent Pharmaceutical dosage forms comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
A pharmaceutical dosage form for administration twice daily, once daily or less frequently, which contains 6′-fluoro-(n-methyl- or n,n-dimethyl)-4-phenyl-4′,9′-dihydro-3′h-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine or a physiologically acceptable salt thereof.. .
Gruenenthal Gmbh
04/23/15
20150111927
 Pharmaceutical diagnostic patent thumbnailnew patent Pharmaceutical diagnostic
The present invention relates to selective cancer treatment regimes based on assaying for the presence or absence of a glutamine or a nucleic acid that encodes glutamine at position 859 of the catalytic p110α subunit of pi3k; methods for producing a transmittable form of information for predicting the responsiveness of patient to (s)-pyrrolidine-1,2-dicarboxylic acid 2-amide 1-({4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin-4-yl]-thiazol-2-yl}-amide), or a pharmaceutically acceptable salt thereof; and a kit thereof.. .
Novartis Ag
04/23/15
20150111904
 Pharmaceutical combination of mek inhibitor and b-raf inhibitors patent thumbnailnew patent Pharmaceutical combination of mek inhibitor and b-raf inhibitors
A novel combination comprising the mek inhibitor n-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)6,8-dimethyl;-2,4,7-trioxo-3,4,6,7-tetrahydro-2h-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide, or solvate thereof, with a b-raf inhibitor, particularly n-{3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising the same and methods of using such combinations and compositions in the treatment of conditions in which the inhibition of mek and/or b-raf is beneficial, eg. Melanoma..
Glaxosmithkline Llc
04/23/15
20150111724
 Visible light responsive photocatalyst by hydrophilic modification using polymer material and a  preparing the same patent thumbnailnew patent Visible light responsive photocatalyst by hydrophilic modification using polymer material and a preparing the same
According to the present invention, the tio2 surface having an increased visible light absorbance due to nitrogen-doping has been modified into a hydrophilic surface using polydimethylsiloxane (pdms), i.e., a silicon-carbon precursor, and thereby significantly improved the removal efficiency of environmental contaminants under visible light. Additionally, the photocatalyst of the present invention for removing environmental contaminants is applicable to environment-friendly fields such as removal of volatile organic compounds, air purification, wastewater treatment and sterilization, and enables to remove contaminants by being attached to the surfaces of external walls of buildings, construction materials, glass windows, sound-absorbing walls, road facilities, signboards, etc., while preventing damages by sunlight..
04/23/15
20150111229
 Method for searching for inhibitor of odor cause by furaneol patent thumbnailnew patent Method for searching for inhibitor of odor cause by furaneol
It is intended to identify a substance inhibiting an odor caused by 2,5-dimethyl-4-hydroxy-3(2h)-furanone. The present invention provides a method for searching for an inhibitor of an odor caused by 2,5-dimethyl-4-hydroxy-3(2h)-furanone, comprising: adding a test substance and 2,5-dimethyl-4-hydroxy-3(2h)-furanone to an olfactory receptor or5k1 or a polypeptide having at least 80% amino acid sequence identity thereto; measuring the response of the olfactory receptor or the polypeptide to 2,5-dimethyl-4-hydroxy-3(2h)-furanone; and identifying a test substance inhibiting the response of the olfactory receptor or the polypeptide, on the basis of the measured response..
Kao Corporation
04/23/15
20150111099
 Lithium ion battery cathode additive, fabrication method thereof, lithium ion battery cathode sheet and lithium ion battery patent thumbnailnew patent Lithium ion battery cathode additive, fabrication method thereof, lithium ion battery cathode sheet and lithium ion battery
A lithium ion battery cathode additive includes a core-shell coating structure formed by elemental lithium powder and a polymer coated on the surface of the elemental lithium powder, where the polymer can dissolve in a carbonic ester solvent, the polymer cannot react with n,n-dimethylformamide (dmf), n,n-dimethylacetamide (dmac), n-2-methyl pyrrolidone (nmp), tetrahydrofuran (thf), acetone or methanol, and the polymer exists stably at a temperature of 0-150° c. The lithium ion battery cathode additive may be added in a lithium ion battery cathode material as a lithium source, for compensating lithium consumption of a battery cathode in a first-time charge-discharge process.
Huawei Technologies Co., Ltd.
04/23/15
20150111038
 Amides of 2-amino-4-arylthiazole compounds and their salts patent thumbnailnew patent Amides of 2-amino-4-arylthiazole compounds and their salts
The present disclosure is directed to salts of n-{4-[2,4-difluoro-3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl}dimethyl-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-5-yl)acetamide and process for the preparation thereof (formula ii).. .
Glenmark Pharmaceuticals S.a.
04/23/15
20150110731
 Inhibitor of odor caused by furaneol patent thumbnailnew patent Inhibitor of odor caused by furaneol
Provided is a substance inhibiting an odor caused by 2,5-dimethyl-4-hydroxy-3(2h)-furanone. An inhibitor of an odor caused by 2,5-dimethyl-4-hydroxy-3(2h)-furanone, comprising a substance inhibiting the response of an olfactory receptor or5k1 as an active ingredient..
Kao Corporation
04/23/15
20150108416
new patent

Coating solution for forming light-absorbing layer, and producing coating solution for forming light-absorbing layer


A coating solution for forming a light-absorbing layer of a czts solar cell, including a hydrazine-coordinated cu chalcogenide complex component (a), a hydrazine-coordinated sn chalcogenide complex component (b) and a hydrazine-coordinated zn chalcogenide complex component (c) dissolved in dimethylsulfoxide; and a method of producing a coating solution forming a light-absorbing layer a czts solar cell, including preparing dimethylsulfoxide having a hydrazine-coordinated cu chalcogenide complex dissolved therein as a first solution, dissolving a hydrazine-coordinated sn chalcogenide complex in dimethylsulfoxide to obtain a second solution, dissolving a hydrazine-coordinated zn chalcogenide complex in dimethylsulfoxide to obtain a third solution, and mixing together the first solution, the second solution and the third solution.. .
Tokyo Ohka Kogyo Co., Ltd.
04/23/15
20150107844
new patent

Well treatment fluids containing biodegradable zirconium crosslinker and methods of using the same


A fracturing fluid containing a hydratable viscosifying polymer and a zirconium acetylacetonate crosslinker provides a green alternative to conventional systems. The zirconium aceylacetonate is dissolved in benzyl alcohol or in a mixture of benzyl alcohol and 2,2-dimethyl-1,3-dioxolan-4(yl)-methanol.
Baker Hughes Incorporated
04/16/15
20150105567

Optically active axially chiral alpha-allenic alcohol, synthesis method and use thereof


The present invention relates to an optically active axially chiral α-allenic alcohol, a synthetic method and use thereof. A method of preparing a high optically active chiral α-allenic alcohol by using propargyl alcohol, aldehyde and chiral α,α-diphenyl-l-prolinol under the protection of tert-butyldimethylsilyl with a mediator zinc bromide.
Shanghai Institute Of Organic Chemistry, Chinese Academy Of Sciences
04/16/15
20150105522

Composite composition of inorganic oxide particles and silicone resin, manufacturing the same, transparent composite, and manufacturing the same


A method of manufacturing a composite composition, having: bonding a dispersant to the surfaces of inorganic oxide particles to provide dispersibility in a hydrophobic solvent to the inorganic oxide particles, and then dispersing the inorganic oxide particles in a hydrophobic solvent; substituting the dispersant bonded to the surfaces of the inorganic oxide particles with a surface modifier, which is a polydimethylsiloxane-skeleton polymer having one functional group at one terminal end, in the hydrophobic solvent in which the organic oxide particles are dispersed to bond the functional group of the polydimethylsiloxane-skeleton polymer to the surfaces of the inorganic oxide particles; and conjugating a silicone resin and the inorganic oxide particles obtained in the previous step, wherein the surface thereof is modified by bonding the polydimethylsiloxane-skeleton polymer having one functional group at one terminal end thereof, to obtain a composite composition.. .
Kyoto University
04/16/15
20150105479

Catalytically active body for the synthesis of dimethyl ether from synthesis gas


The invention relates to a catalytically active body for the synthesis of dimethyl ether from synthesis gas. In particular, the invention relates to an improved catalytically active body for the synthesis of dimethyl ether, whereby the components of the active body comprise a methanol active component and an acid component comprising a zeolitic material being crystallized by means of one or more alkenyltrialkylammonium cation r1r2r3r4n+-containing compounds as structure directing agent.
Basf Se
04/16/15
20150105355

4-dedimethylamino tetracycline compounds


The present invention pertains, at least in part, to novel substituted 4-dedimethylamino tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for minocycline and tetracycline compounds in general, such as blocking tetracycline efflux and modulation of gene expression..
Paratek Pharmaceuticals, Inc.
04/16/15
20150105353

Stable composition for controlling biological growth and using same in oil field applications


A stabilized composition is disclosed which contains at least two biocides, particularly at least two non-oxidizing biocides. In one embodiment, the composition contains a phosphonium sulfate compound combined with a dialkyl dimethyl quaternary amine compound.
Lonza Inc.
04/16/15
20150105305

High elastohydrodynamic shear strength fluid compositions


A lubrication fluid including cyclic hydrocarbons in combination with dimethylsilicone fluids and/or di-alkyl or di-cycloalkyl or alkyl-cycloalkyl, or mixtures thereof, and di-end-capped polypropylene oxides or highly branched esters to produce very high traction elastohydrodynamic (ehd) traction fluids and to modify the low temperature viscometric properties of the mixed fluids without adversely affecting the very high elastohydrodynamic shear strength or traction coefficients of the very high shear strength cyclic hydrocarbon fluid in the resulting mixed fluids with improved low temperature viscosity.. .
Santolubes Incorporation
04/16/15
20150104378

Synthesis of borosilicate ton-framework type molecular sieves


A method is disclosed for synthesizing borosilicate ton-framework type molecular sieves in a hydroxide media using a 1,3-dimethylimidazolium cation or a 1,4-bis(n-methylimidazolium)butane dication as a structure directing agent.. .
04/09/15
20150099913

Methanol conversion process


A methanol conversion process comprises contacting a feedstream comprising methanol, optionally with dimethyl ether or other oxygenates with a catalyst comprising a physical mixture of a molecular sieve, preferably an intermediate or small pore size zeolite such as an mfi zeolite, with a basic metal oxide to provide extended catalyst cycle life by reducing the incidence of coke formation. The process may be applied to the methanol-to-gasoline (mtg), methanol to distillate (mod), methanol-to-olefins (mto), methanol-to-chemicals (mtc) and combination processes such as the mto/ocp process..
Exxonmobil Research And Engineering Company
04/09/15
20150099889

Method for preparation of medetomidine with chloroacetone


The invention discloses a method for the preparation of medetomidine starting from 1-bromo 2,3-dimethylbenzene and chloroacetone.. .
Lonza Ltd
04/09/15
20150099760

Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof


This invention relates to (1) process of making 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and salts thereof; (2) novel salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide; (3) pharmaceutical compositions comprising the same; and (4) methods of treatment using the same.. .
Novartis Ag
04/09/15
20150099736

Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activity


Wherein r1, r2, r5 and r6 are independently selected from hydrogen, hydroxy, methyl, trifluoromethyl, hydroxymethyl, methoxy, trifluoromethoxy, methylamino and dimethylamino; r3, and r4 are independently selected from hydrogen, hydroxy, c1-c3 alkyl, fluoro-(c1-c3)-alkyl, hydroxy-(c1-c3)-alkyl, c1-c3 alkoxy, fluoro-(c1-c3)-alkoxy, hydroxy-(c1-c3)-alkoxy, —n(r11)—r12, -alk-n(r11)—r12, —o-alk-n(r11)—r12, —c(═o)oh, carboxy-(c1-c3)-alkyl, or —c(═o)—nh—r13; alk is a straight or branched chain divalent c1-c6 alkylene radical; r7 and r8 are independently selected from hydrogen, hydroxy, or c1-c3 alkoxy; x is a straight chain divalent c1-c3 alkylene radical, optionally substituted on one or more carbons by r9 and/or r10; w is selected from —c(═o)—n(—r16)— or —n(—r17)—c(═o)—; y is hydrogen, c1-c3 alkyl, c1-c3 alkoxy, or halo; and q is selected from optionally substituted phenyl, optionally substituted cyclohexyl, or an optionally substituted 6-membered monocyclic heteroaryl ring.. .
04/09/15
20150099724

Novel crystals and process of making 5-(-methyl)-2-methoxy-benzoic acid


The present invention relates to a novel crystals of 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid and methods of making the zwitterion of 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid.. .
Furiex Pharmaceuticals, Inc.
04/09/15
20150099631

Crystalline form a of 1,5-dimethyl-6-thioxo-3-(2,2,7-trifluoro-3-oxo-4-(prop-2-ynyl)-3,4-dihydro-2h-benzo[b][1,4]oxazin-6-yl)-1,3,5-triazinane-2,4-dione


The present invention relates to a novel crystalline form a of 1,5-dimethyl-6-thioxo-3-(2,2,7-trifluoro-3-oxo-4-(prop-2-ynyl)-3,4-dihydro-2h-benzo[b][1,4]oxazin-6-yl)-1,3,5-triazinane-2,4-dione. The invention also relates to a process for the production of this crystalline form and formulations for plant protection which contains the novel crystalline form of 1,5-dimethyl-6-thioxo-3-(2,2,7-trifluoro-3-oxo-4-(prop-2-ynyl)-3,4-dihydro-2h-benzo[b][1,4]oxazin-6-yl)-1,3,5-triazinane-2,4-dione..
Basf Se
04/09/15
20150099227

Resin for toner and toner


The present invention provides a crystalline polyester resin for toner that has, when used as a resin for toner, a sharp melt property, excellent fixing performance and blocking property and a preferable charging performance. Provided is a crystalline polyester resin for toner, which is obtained by condensation polymerization of a dicarboxylic acid component containing at least one compound selected from the group consisting of terephthalic acid, 2,6-naphthalenedicarboxylic acid and derivatives thereof, and a diol component containing at least one compound selected from the group consisting of 2-methyl-1,3-propanediol, 2,2-dimethyl-1,3-propanediol and derivatives thereof, the crystalline polyester resin having a weight-average molecular weight of not less than 5000 and not more than 50000..
Canon Kabushiki Kaisha
04/09/15
20150099072

Method for forming ti-containing film by peald using tdmat or tdeat


A method for forming a ti-containing film on a substrate by plasma-enhanced atomic layer deposition (peald) using tetrakis(dimethylamino)titanium (tdmat) or tetrakis(diethylamino)titanium (tdeat), includes: introducing tdmat and/or tdeat in a pulse to a reaction space where a substrate is placed; continuously introducing a nh3-free reactant gas to the reaction space; applying rf power in a pulse to the reaction space wherein the pulse of tdmat and/or tdeat and the pulse of rf power do not overlap; and repeating the above steps to deposit a ti-containing film on the substrate.. .
Asm Ip Holding B.v.
04/09/15
20150098915

Novel surfactant-free self-reversible reverse latex, and use of same as a thickening agent in a cosmetic composition


Disclosed is a self-reversible reverse latex including: a) 25-80% by mass of a cross-linked anionic polyelectrolyte (p), resulting from the polymerisation, for 100 mole percent: i)—of a molar proportion 30% and 95% of monomeric units from at least one monomer including a free, partially- or totally-salified strong acid function; and ii)—of a molar proportion >0% and <5% of at least one monomer with diethylenic or polyethylenic crosslinking; b) 0.5-10% by mass of a terpolymer of stearyl methacrylate, pentacosaethoxylated behenyl methacrylate and n,n-dimethylacrylamide, resulting from the polymerisation, for 100 mole percent: of 80-95 mole percent of stearyl methacrylate, of 2.5-10 mole percent of n,n-dimethylacrylamide, and of 2.5-10 mole percent of pentacosaethoxylated behenyl methacrylate, c) 5-40% by mass of at least one oil, and d) 0.1-40% by mass of water; method of preparing same and use thereof as a thickener.. .
Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic
04/02/15
20150094497

Reaction system and process for preparing polymethoxy dimethyl ether


The invention relates to a reaction system and process for continuously preparing polymethoxy dimethyl ether (dmm3-8) by a continuous acetalization reaction between an aqueous formaldehyde solution or paraformaldehyde and methanol in the presence of a functionalized acidic ionic liquid as a catalyst. The reaction system of the invention preferably comprises a formaldehyde-concentrating unit, a vacuum-drying unit, an acetalization reaction unit, a product-separating unit and a catalyst-regenerating unit.
Suzhou Ost Advanced Materials Co., Ltd.
04/02/15
20150094321

Combination


The present invention relates to a method of treating cancer in a human and to pharmaceutical combinations useful in such treatment. In particular, the method relates to a cancer treatment method that includes administering n-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2h-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide, or a pharmaceutically acceptable salt or solvate thereof, and n-{(1s)-2-amino-1-[(3,4-difluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-furancarboxamide, or a pharmaceutically acceptable salt thereof, to a human in need thereof..
Glaxosmithkline Llc
04/02/15
20150094316

Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine


Liquid formulations of lactic acid addition salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine are provided. .
H. Lundbeck A/s
04/02/15
20150094283

Combination


The present invention relates to a method of treating cancer in a human and to pharmaceutical combinations useful in such treatment. In particular, the method relates to a cancer treatment method that includes administering 5-[[4-[(2,3-dimethyl-2h-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide, or a pharmaceutically acceptable salt thereof, and n-{(1s)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-thiophenecarboxamide, or a pharmaceutically acceptable salt thereof, to a human in need thereof..
Glaxosmithkline Llc
04/02/15
20150092004

Methods for forming functionalized carbon black with amino-terminated polyfluorodimethylsiloxane for printing


A method for forming functionalized carbon black useful for uniform dispersion in a surface material of a printing system component includes providing carbon black; providing a fluoropolymer having a terminal amino group; and mixing the amino-terminated fluoropolymer and the carbon black, wherein the fluoropolymer is amino-terminated pdms.. .
Xerox Corporation
04/02/15
20150090075

Method for the removal and recovery of metals and precious metals from substrates


A method for removing metal and/or precious metal-containing depositions from substrates, wherein said substrate is subjected to treatment with an organo amine protectant component p and an inorganic active component a. Component p may be formed in situ by reaction with component r.
Materion Corporation
03/26/15
20150087845

Process for preparation of substituted 3'-hydroazino-diphenyl-3-carboxylic acid compounds


The present invention provides a process for the preparation of substituted 3′-hydrazino-biphenyl-3-carboxylic acid compounds. The present invention further provides a process for the preparation of 3′-{n′-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-pyrazol-4-ylidene]hydrazino}-2′-hydroxybiphenyl-3-carboxylic acid, its intermediate compounds and pharmaceutically acceptable salts thereof..
Glenmark Generics Limited
03/26/15
20150087711

Minocycline compounds and methods of use thereof


Methods and compositions for using a tetracycline compound to treat bacterial infections are described. In one embodiment, for example, the invention provides a method of treating a subject for an infection, comprising administering to said subject an effective amount of 9-[(2,2-dimethyl-propyl amino)-methyl]-minocycline or a salt thereof, such that said subject is treated, wherein said infection is selected from the group consisting of mssa, mrsa, b-streptococci, viridans streptococci, enterococcus, or combinations thereof..
Paratek Pharmaceuticals, Inc.- 124418
03/26/15
20150087511

Pesticidal mixtures


The present invention relates to synergistic mixtures comprising, as active components one insecticidal compound i selected from the group of acrinathrin, allethrin, alpha-cypermethrin, beta-cypermethrin, bifenthrin, cycloprothrin, cyfluthrin, cypermethrin, cyphenothrin, deltamethrin, dimefluthrin, esfenvalerate, etofenprox, fenpropathrin, fenvalerate, flucythrinate, imiprothrin, permethrin, prallethrin, profluthrin, pyrethrin i, pyrethrin ii, resmethrin, silafluofen, tau-fluvalinate, tetramethrin, theta-cypermethrin, tralomethrin, transfluthrin and zeta-cypermethrin; and one fungicidal compound ii selected from the group of azoxystrobin, coumethoxystrobin, coumoxystrobin, dimoxystrobin, enestroburin, fluoxastrobin, kresoxim-methyl, metominostrobin, orysastrobin, picoxystrobin, pyraclostrobin, pyrametostrobin, pyraoxystrobin, pyribencarb, trifloxysstrobin, 2-(ortho-((2,5-dimethylphenyl-oxymethylen)phenyl)-3-methoxy-acrylic acid methyl ester, 2-(2-(3-(2,6-dichlorophenyl)-1-methyl-allylideneaminooxymethyl)-phenyl)-2-methoxyimino-n-methyl-acetamide in synergistic effective amounts.. .
Basf Se
03/26/15
20150086713

Non-fluoro hydrophobic aqueous-based polyurethane resin dispersion, and production method and use thereof


The present invention provides a cross-linking non-fluoro hydrophobic aqueous polyurethane dispersion, which is produced by selecting a compound comprising alcohols, amines, acids, saturated or unsaturated (double-bonded or epoxidized) aliphatic long chain carbon-carbon groups or polydimethylsiloxane comprising alcohol groups, amines, oxosilane to be reacted with ipdi to obtain a pu prepolymer; adding a compound having tertiary amines to neutralize the carboxylic acid of pu prepolymer and adding water to disperse the pu prepolymer; and adding a ambient temperature cross-linking agent to obtain a cross-linking hydrophobic aqueous pu dispersion of the present invention. The hydrophobic aqueous-based pu resin has no fluorine which is friendly to the environment, and may further self cross-links on its applications on fabric, paper, wood, glass and metal surfaces, respectively on drying at ambient temperature which is energy saving process.
Tamkang University
03/26/15
20150083918

Method of detecting a propellant gas


A method and a system for detecting the presence of propellant gas in a gaseous sample exploit laser light especially in the 3.30-3.5 μm range. The propellant can be propane, n-butane, i-butane, dimethyl ether, methyl ethyl ether, hfa 134a, hfa 227, or any other propellant exhibiting absorption in the requisite wavelength range.
03/26/15
20150083025

Fluoropolymer compositions


The present invention relates to a composition for solubilizing a fluoropolymer, comprising a solvent blend of a) compound of formula (i) r1 c(=0)nr2r3 wherein r1 and r2 and r3 are defined as in the specification and b) dimethylsulfoxide (dmso). The invention also relates to the process for the preparation of the composition and its uses.
Rhodia Operations
03/19/15
20150080546

Production and use of 3,4' and 4,4'-dimethylbiphenyl isomers


In a process for producing 3,4′ and/or 4,4′ dimethyl-substituted biphenyl compounds, a feed comprising toluene is contacted with hydrogen in the presence of a hydroalkylation catalyst under conditions effective to produce a hydroalkylation reaction product comprising (methylcyclohexyl)toluenes. At least part of the hydroalkylation reaction product is dehydrogenated in the presence of a dehydrogenation catalyst under conditions effective to produce a dehydrogenation reaction product comprising a mixture of dimethyl-substituted biphenyl isomers.
Exxonmobil Chemical Patents Inc.
03/19/15
20150080545

Production and use of 3,4' and 4,4'-dimethylbiphenyl isomers


In a process for producing 3,4′ and/or 4,4′ dimethyl-substituted biphenyl compounds, a feed comprising toluene is contacted with hydrogen in the presence of a hydroalkylation catalyst under conditions effective to produce a hydroalkylation reaction product comprising (methylcyclohexyl)toluenes. At least part of the hydroalkylation reaction product is dehydrogenated in the presence of a dehydrogenation catalyst under conditions effective to produce a dehydrogenation reaction product comprising a mixture of dimethyl-substituted biphenyl isomers.
Exxonmobil Chemical Patents Inc.
03/19/15
20150080475

Memantine protects inflammation-related degeneration of dopamine neurons through inhibition of over-activated microglia and release of neurotrophic factors from astroglia


This invention relates to a method of treating opiate addiction caused by microglial over-activation-mediated dopamine (da) neurons damage, comprising administering a human in need of such treatment 0.01-0.08 mg/kg of 1-amino-3,5-dimethyladamantane hydrochloride orally per day.. .
03/19/15
20150080431

Pharmaceutical compositions for the treatment of cftr-mediated disorders


The present invention relates to the use of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (compound 1), solids forms, and pharmaceutical compositions thereof for the treatment of cftr-mediated diseases, particularly cystic fibrosis, in patients possessing specific genetic mutations. The present invention also relates to the use of compound 1 in combination with 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid (compound 2), and compound 1 in combination with (s)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl)cyclopropanecarboxamide (compound 3), for the treatment of cftr-mediated diseases, particularly cystic fibrosis, in patients possessing specific genetic mutations.
Vertex Pharmaceuticals Incorporated
03/19/15
20150080417

Therapeutic composition to treat lesions caused by herpes simplex virus


The present invention is generally directed toward therapeutic compositions for treating infections caused by herpes simplex virus (“hsv”). The therapeutic compositions meet a long felt need in the art of providing a treatment for lesions that result from hsv that drastically reduce the duration of a cold sore when vesicles have already appeared and a treatment that will prevent the outbreak of a lesion and formation of vesicles when applied in the prodromal stage.
G2l Touch, Inc.
03/19/15
20150080287

Method for preparation of 2-(2,3-dimethylphenyl)-1-propanal


The invention discloses a method for preparation of 2-(2,3-dimethylphenyl)-1-proponal from bromo 2,3-dimethyl-benzene and aceton, its use in perfumes and its use for the preparation of medetomidine.. .
Lonza Ltd
03/19/15
20150080286

Fabric softener active composition and making it


Reacting at least one tris-(2-hydroxyethyl)-amine fatty acid ester with dimethylsulfate at a molar ratio of dimethylsulfate to amine nitrogen of from 0.79 to 0.94 until the reaction mixture has a total amine number of from 7 to 20 mg koh/g provides novel fabric softener active compositions with a low content of methanol, comprising from 65 to 98% by weight of tris-(2-hydroxyethyl)-methylammonium methylsulfate fatty acid esters and from 1 to 1500 ppm methanol.. .
Evonik Industries Ag
03/19/15
20150079786

Method and solution for cleaning metal residue


A solution for processing devices is provided, comprising an activator comprising at least one of pyridine, pyrole, pyrrolidine, pyrimidine, n,n-dimethylformamide, tetraethylamine chloride, 4 pyridinethiol, or other organic compounds with a single n with a lone pair electron activator and an etchant comprising at least one of thionly chloride, cl2, br2, i2, sof2, sof4, so2cl2, sobr2, s2o6f2, hso3f, or c2cl4o2.. .
Lam Research Corporation
03/19/15
20150079482

Electrolyte for li storage battery and li storage battery


The present invention provides an electrolyte for a li storage battery comprising a compound that can improve safety of a storage battery without causing the degradation in performances thereof and a li storage battery comprising the electrolyte. The electrolyte comprises at least 1,1-diphenylethane the li storage battery comprises the electrolyte.
Jx Nippon Oil & Energy Corporation
03/19/15
20150079180

Nanoparticle compositions of dimethyl fumarate


Disclosed herein are compositions of dimethyl fumarate exhibiting reduced gastrointestinal irritation and related side effects.. .
Xenoport, Inc.
03/19/15
20150079157

Composition comprising purine derivatives or salt thereof for preventing or treating atopic dermatitis


The present invention provides a pharmaceutical composition for preventing or treating atopic dermatitis comprising 2-amino-1,9-dimethylpurin-6-one or its pharmaceutically acceptable salt as an active ingredient. And also, the present invention provides a cosmetic composition for improving atopic dermatitis comprising 2-amino-1,9-dimethylpurin-6-one or its pharmaceutically acceptable salt; and a food (i.e., a functional food) for preventing or improving atopic dermatitis comprising 2-amino-1,9-dimethylpurin-6-one or its pharmaceutically acceptable salt..
Daewoong Co., Ltd.
03/19/15
20150079156

Liposomal delivery system


The present invention is directed to a liposomal delivery system comprising defined lipid components, including dimethyldioctadecylammonium and other lipid components and a stabilizing agent, which may be used in the delivery of bioactive agents to a subject in need thereof. The liposomal delivery system of the invention provide improvements in terms of delivery and stability.
The Queen's University Of Belfast
03/19/15
20150079030

3'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)


An improved thrombopoietin mimetic, the bis-(monoethanolamine) salt of 3′-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid.. .
Glaxosmithkline Llc
03/19/15
20150078991

Method for preparing zeolite ssz-35..test edan


A method for making zeolite ssz-35 is disclosed using a n,n-dimethylazonanium cation as a structure directing agent.. .
03/19/15
20150078990

Method for preparing zeolite ssz-35


A method for making zeolite ssz-35 is disclosed using a n,n-diethyl-2,3-dimethylpiperidinium cation or a n,n-dimethyl-2-isopropylpiperidinium cation as a structure directing agent.. .
03/19/15
20150075623

Valve device, storage system for liquefied gas fuel, vehicle, and storage liquefied gas fuel


A first vapor phase valve including a housing, a flow passage in the housing, a main valve to block or open the flow passage, and an excess flow valve to block the flow passage when vapor phase dimethyl ether flows through the flow passage. The first vapor phase valve includes: a pressure chamber communicating with a pressure opening portion of the housing and a fixed shaft connected to the excess flow valve to maintain the excess flow valve in an open state by using pressure of liquid phase dimethyl ether flowing into the pressure chamber from the pressure opening portion.
Isuzu Motors Limited
03/19/15
20150075471

Methods for the preparation and delivery of fuel compositions


A process for generating a main fuel composition comprising methanol and water and not more than 20% by weight dimethyl ether, and a fumigant comprising dimethyl ether, the process comprising: providing a pre-fuel composition comprising methanol and dimethyl ether, adding water to the pre-fuel composition to cause or aid evaporation of at least a portion of the dimethyl ether from the pre-fuel composition, collecting the portion of dimethyl ether evaporated from the pre-fuel composition for use as a fumigant, and using the remainder of the pre-fuel composition comprising methanol and water as a main fuel composition. The water may be at a temperature above ambient..
Gane Energy & Resources Pty Ltd
03/12/15
20150073149

Formation of n-protected bis-3,6-(4-aminoalkyl)-2,5,diketopiperazine


The disclosed embodiments detail improved methods for the synthesis of diketopiperazines from amino acids. In particular improved methods for the cyclocondensation and purification of n-protected 3,6-(aminoalkyl)-2,5-diketopiperazines from n-protected amino acids.
Mannkind Corp
03/12/15
20150073061

Coated microfluidic devices and methods of making


We describe a method of layer-by-layer deposition of a plurality of layers of material onto the wall or walls of a channel of a microfluidic device, the method comprising: loading a tube with a series of segments of solution, a said segment of solution bearing a material to be deposited; coupling said tube to said microfluidic device; and injecting said segments of solution into said microfluidic device such that said segments of solution pass, in turn, through said channel depositing successive layers of material to perform said layer-by-layer deposition onto said wall or walls of said channel. Embodiments of the methods are particularly useful for automated surface modification of plastic, for example pdms (poly(dimethylsiloxane)), microchannels.
Cambridge Enterprise Limited
03/12/15
20150072400

System for cultivation and processing of microorganisms, processing of products therefrom, and processing in drillhole reactors


Methods of cultivating autotrophic microorganisms, particularly microalgae or diatoms, in a bioreactor by entraining a culture of the microorganisms in a tenuous, gelated, thixotrophic carrier medium having nutrients therefor and moving the medium along a passage at a sufficiently slow speed to enable laminar flow which in cross section is closed and which has transparent walls through which the culture is irradiated to enable photosynthesis. The method includes effecting convective turnover of the culture and medium as they flow along the passage by differentially heating the medium laterally relative to the flow direction so as to produce a generally helical flow of the culture and medium.
03/12/15
20150072252

Fuel cell membrane


The fuel cell membrane is a polymer electrolyte (or polyelectrolyte) membrane formed from a blend of sulfonated poly(ether ether ketone) (speek) and phosphonated polysulfone in the ester form (ppsu-e), where the sulfonated poly(ether ether ketone) and the phosphonated polysulfone each form about 50 wt % of the polyelectrolyte membrane. The polyelectrolyte membrane is made by dissolving a mixture of speek and ppsu in the ester form (ppsu-e) in dimethylacetamide (dmac) at room temperature to form a solution.
King Fahd University Of Petroleum And Minerals
03/12/15
20150072079

Protecting substrates against damage by fire


A process for protecting a metal, wood or plastics substrate exposed to fire risk from hydrocarbons, comprising coating the substrate with an intumescent composition comprising a polydimethylsiloxane (a) of degree of polymerisation at least 300 siloxane units, said polydimethylsiloxane containing reactive hydroxyl or hydrolysable groups bonded to silicon, and a crosslinking agent (b) containing hydrolysable groups reactive with the reactive groups of (a) in the presence of moisture, expandable graphite and a titanate catalyst for the reaction between the reactive hydroxyl or hydrolysable groups of polydimethylsiloxane (a) and the crosslinking agent (b).. .
Dow Corning Corporation


Popular terms: [SEARCH]

Dimethyl topics: Physiologic, Hydrochloric Acid, Fresnel Zone, Aberration, Ophthalmic, Liquid Crystal, Imaging System, Pharmaceutically Acceptable Salt, Pharmaceutically Acceptable Salts, Chloric Acid, Tartaric Acid, Fumaric Acid, Antagonist, Bradykinin, Enantiomer

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Dimethyl for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Dimethyl with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         













0.7562

3235

3 - 0 - 72